Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug–drug interactions and interindividual differences in transporter and metabolic enzyme functions

西伐他汀 氟伐他汀 药理学 阿托伐他汀 药代动力学 普伐他汀 瑞舒伐他汀 皮塔伐他汀 羟甲基戊二酰辅酶A还原酶 他汀类 HMG-CoA还原酶 化学 CYP3A4型 药物相互作用 辛伐他汀 还原酶 医学 胆固醇 细胞色素P450 新陈代谢 生物化学
作者
Yoshihisa Shitara,Yuichi Sugiyama
出处
期刊:Pharmacology & Therapeutics [Elsevier BV]
卷期号:112 (1): 71-105 被引量:566
标识
DOI:10.1016/j.pharmthera.2006.03.003
摘要

3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are widely used for the treatment of hypercholesterolemia. Their efficacy in preventing cardiovascular events has been shown by a large number of clinical trials. However, myotoxic side effects, sometimes severe, including myopathy or rhabdomyolysis, are associated with the use of statins. In some cases, such toxicity is associated with pharmacokinetic alterations. In this review, the pharmacokinetic aspects and physicochemical properties of statins are reviewed in order to understand the mechanism governing their pharmacokinetic alterations. Among the statins, simvastatin, lovastatin and atorvastatin are metabolized by cytochrome P450 3A4 (CYP3A4) while fluvastatin is metabolized by CYP2C9. Cerivastatin is subjected to 2 metabolic pathways mediated by CYP2C8 and 3A4. Pravastatin, rosuvastatin and pitavastatin undergo little metabolism. Their plasma clearances are governed by the transporters involved in the hepatic uptake and biliary excretion. Also for other statins, which are orally administered as open acid forms (i.e. fluvastatin, cerivastatin and atorvastatin), hepatic uptake transporter(s) play important roles in their clearances. Based on such information, pharmacokinetic alterations of statins can be predicted following coadministration of other drugs or in patients with lowered activities in drug metabolism and/or transport. We also present a quantitative analysis of the effect of some factors on the pharmacokinetics of statins based on a physiologically based pharmacokinetic model. To avoid a pharmacokinetic alteration, we need to have information about the metabolizing enzyme(s) and transporter(s) involved in the pharmacokinetics of statins and, along with such information, model-based prediction is also useful.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
核桃发布了新的文献求助20
1秒前
杭啊发布了新的文献求助10
1秒前
NexusExplorer应助HE采纳,获得10
1秒前
A73579完成签到,获得积分10
2秒前
3秒前
3秒前
4秒前
wang发布了新的文献求助10
4秒前
wanci应助李老头采纳,获得10
5秒前
7秒前
南南发布了新的文献求助10
7秒前
7秒前
杭啊完成签到,获得积分10
8秒前
jun完成签到 ,获得积分10
8秒前
lu777完成签到,获得积分20
8秒前
嘟嘟嘟完成签到,获得积分10
8秒前
非法所得发布了新的文献求助10
9秒前
Ava应助he采纳,获得10
11秒前
勇往直前发布了新的文献求助10
12秒前
666发布了新的文献求助10
13秒前
初晨发布了新的文献求助10
13秒前
科研通AI6.2应助无言采纳,获得10
14秒前
研友_VZG7GZ应助科研通管家采纳,获得10
15秒前
ysj应助科研通管家采纳,获得10
15秒前
打打应助科研通管家采纳,获得10
15秒前
15秒前
lxy完成签到,获得积分20
15秒前
molihuakai应助科研通管家采纳,获得10
15秒前
烟花应助科研通管家采纳,获得10
16秒前
16秒前
ysj应助科研通管家采纳,获得10
16秒前
16秒前
风行者完成签到,获得积分10
16秒前
16秒前
丘比特应助科研通管家采纳,获得10
16秒前
16秒前
田様应助科研通管家采纳,获得10
16秒前
爆米花应助科研通管家采纳,获得10
17秒前
英姑应助美丽大板砖采纳,获得30
17秒前
lu777发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
HYDROLYSE ACIDE DE QUELQUES DIOXASPIROCYCLANES 1314
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Navigating Normative Orders. Interdisciplinary Perspectives 800
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7746178
求助须知:如何正确求助?哪些是违规求助? 9294054
关于积分的说明 20223336
捐赠科研通 7326031
什么是DOI,文献DOI怎么找? 3308059
关于科研通互助平台的介绍 2460040
邀请新用户注册赠送积分活动 2319591